WuXi AppTec's (HKG:2359) biology business segment contained a cybersecurity breach involving unauthorized access on its DNA-encoded library platform, according to a Tuesday filing with the Hong Kong bourse.
The drug research and development company said it found no evidence that other systems were compromised or that the accessed data was misused or published.
WuXi AppTec has notified the affected customers. The incident did not disrupt the company's normal operations, IT systems, or client services, it added.